author-photo

Christoph Weinlinger

12

Papers

32

Citations

Citation Trend

Filter By

Papers (8) Sort By

Journal Conference Others

Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access program

2021 Therapeutic Advances in Medical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Successful immune checkpoint inhibition in an EGFR-mutant lung cancer patient refractory to epidermal growth factor receptor tyrosine kinase inhibitor treatment

2020 Anti-Cancer Drugs
Show All
- Source
- Cite
- Save
Citations (0)
Later-Line Treatment with Lorlatinib in ALK- and ROS1-Rearrangement-Positive NSCLC: A Retrospective, Multicenter Analysis.

2020 Pharmaceuticals
Show All
- Source
- Cite
- Save
Citations (2)
P2.14-46 Treatment Observations and Clinical Experience with Lorlatinib in Pretreated ALK and ROS1 Rearranged NSCLC Patients

2019 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Rapid clinical and radiological responses with larotrectinib in a patient with TRK-fusion–positive metastatic lung cancer

2019 Clinical Lung Cancer
Show All
- Source
- Cite
- Save
Citations (1)
Molecular Characterization of Circulating Tumor Cells Enriched by A Microfluidic Platform in Patients with Small-Cell Lung Cancer

2019 Cells
Show All
- Source
- Cite
- Save
Citations (15)
Treatment of ALK-rearranged non-small-cell lung cancer with brigatinib as second or later lines: real-world observations from a single institution

2019 Anti-Cancer Drugs
Show All
- Source
- Cite
- Save
Citations (6)
Social Learning and the Long Journey to Culture

2014 Human ethology bulletin
- Christoph Weinlinger
- Anna Ensberger
Show All
- Source
- Cite
- Save
Citations (0)